Hallucinations

Also known as: Hallucination / Hallucinations, unspecified / Hallucinations (finding) / Hallucination NOS / Hallucinating

Drug	Drug Name	Drug Description
DB05316	Pimavanserin	A second generation atypical antipsychotic used for the treatment of hallucinations and delusions caused by Parkinson's Disease.
DB00391	Sulpiride	A selective D2 dopamine receptor antagonist indicated to treat chronic and acute schizophrenia.

Drug	Drug Name	Target	Type
DB05316	Pimavanserin	5-hydroxytryptamine receptor 2A	target
DB05316	Pimavanserin	5-hydroxytryptamine receptor 2C	target
DB05316	Pimavanserin	Sigma non-opioid intracellular receptor 1	target
DB05316	Pimavanserin	Cytochrome P450 3A4	enzyme
DB05316	Pimavanserin	Cytochrome P450 3A5	enzyme
DB05316	Pimavanserin	Cytochrome P450 2J2	enzyme
DB05316	Pimavanserin	Cytochrome P450 2D6	enzyme
DB00391	Sulpiride	Dopamine D2 receptor	target
DB00391	Sulpiride	Dopamine D3 receptor	target
DB00391	Sulpiride	Cholinesterase	enzyme
DB00391	Sulpiride	Carbonic anhydrase 2	target
DB00391	Sulpiride	Carbonic anhydrase 3	target
DB00391	Sulpiride	Serum albumin	carrier
DB00391	Sulpiride	Solute carrier family 22 member 1	transporter
DB00391	Sulpiride	Solute carrier family 22 member 2	transporter
DB00391	Sulpiride	Multidrug and toxin extrusion protein 1	transporter
DB00391	Sulpiride	Multidrug and toxin extrusion protein 2	transporter
DB00391	Sulpiride	Dopamine D4 receptor	target
DB00391	Sulpiride	Solute carrier family 22 member 3	transporter
DB00391	Sulpiride	P-glycoprotein 1	transporter
DB00391	Sulpiride	ATP-binding cassette sub-family G member 2	transporter

Drug	Drug Name	Phase	Status	Count
DB05316	Pimavanserin	2	Completed	1
DB01221	Ketamine	3	Completed	1
DB00295	Morphine	3	Completed	1